SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Ischemic Penumbra: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

Chat with this issue

DOI: 10.62487/saimsara6f777af3

Editorial note
• Last update: 2026-03-29 13:08:35
What is this paper about
This paper shows that the ischemic penumbra is not just a fading border around stroke core, but a dynamic and biologically active therapeutic target whose fate depends on collaterals, metabolism, BBB integrity, and how fast true reperfusion is achieved. The full read is worth it because it separates the real clinical signal from the hype—showing where tissue-based stroke decisions already work, where imaging and software still disagree, and which next-generation strategies may actually preserve salvageable brain.
Found an issue in this paper? Email admin@saimsara.com


Abstract: This review aims to synthesize recent evidence regarding the pathophysiology, multi-modal imaging characterization, and therapeutic strategies targeting the ischemic penumbra in both experimental models and clinical populations. The review utilises 2249 original studies with 631707 total participants (topic deduplicated ΣN). This evidence map suggests that the ischemic penumbra is best understood as a dynamic, biologically active compartment whose clinical relevance depends on whether reperfusion reaches viable tissue before it is consumed. Across the mapped literature, penumbral volume declined by about 3.1 mL per hour from onset in one large cohort, yet substantial salvageable tissue often persisted in late presenters, and reperfused penumbra volume showed strong prognostic value with an AUC of 0.946 for favorable 90-day outcome in one cohort. The dominant signals support a central role for collateral circulation, metabolic stress, BBB integrity, and spreading depolarizations in determining tissue fate, while multimodal imaging—including CTP, alternative MRI approaches, and emerging machine-learning tools—continues to refine identification of patients most likely to benefit from reperfusion. Clinically, the mapped evidence supports tissue-based rather than clock-based decision-making, particularly for EVT selection in extended windows where larger penumbras were associated with greater benefit and small penumbras could trend toward harm. At the same time, heterogeneity in imaging thresholds, software outputs, and translational maturity indicates that penumbra-guided care remains constrained by standardization gaps rather than by lack of biological rationale. Future research should prioritize prospective validation of harmonized imaging and metabolic viability markers, together with trials of adjunctive strategies that preserve microcirculation, suppress inflammatory injury and spreading depolarizations, or stabilize the BBB while reperfusion is pursued.

Keywords: Ischemic penumbra; CT perfusion; Mechanical thrombectomy; Neuroprotective biomarkers; Deep learning segmentation; Blood-brain barrier leakage; Oxygen extraction fraction; Penumbra salvage volume; Cerebral blood flow; Remote ischemic postconditioning, Stroke

Review Stats

Get access to the full paper

Unlock the full evidence map

The full evidence review, including the Introduction, Methods, Results, Discussion, Conclusion, figures, and complete reference index, opens after purchase or sign-in. The Evidence Object JSON is a separate machine-readable evidence product: a concentrated synthesis of results, topic-level evidence, and discussion across original and non-original studies. It can be directly input into your LLM, agent, or RAG workflow.

Reference Index (218)
Article views: —
Follow us

© 2026 SAIMSARA Journal Impressum Published by ML in Health Science GbR